Vertex Pharmaceuticals (VRTX) Cash & Equivalents Growth (5y) (2014 - 2026)
Vertex Pharmaceuticals (VRTX) Cash & Equivalents Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.72% |
| Dec 31, 2025 | -3.22% |
| Sep 30, 2025 | -1.61% |
| Jun 30, 2025 | 0.58% |
| Mar 31, 2025 | 5.40% |
| Dec 31, 2024 | 8.00% |
| Sep 30, 2024 | 9.05% |
| Jun 30, 2024 | 6.81% |
| Mar 31, 2024 | 25.91% |
| Dec 31, 2023 | 31.37% |
| Sep 30, 2023 | 34.99% |
| Jun 30, 2023 | 36.46% |
| Mar 31, 2023 | 36.01% |
| Dec 31, 2022 | 44.53% |
| Sep 30, 2022 | 45.95% |
| Jun 30, 2022 | 48.06% |
| Mar 31, 2022 | 179.49% |
| Dec 31, 2021 | 41.83% |
| Sep 30, 2021 | 54.21% |
| Jun 30, 2021 | 58.52% |